Patients Undergoing Gynecologic Cancer Surgery Face Insurance-Based Disparities and Financial Toxicity
For a study, researchers sought to assess the association between insurance status and clinical...
Read More
Economy
Financial Toxicity in Gynecologic Cancers: Patient-Reported Drivers
For a study, researchers sought to comprehend the effects that treatment-related financial burden...
Read More
Financial Toxicity Has ‘Profound Impact’ in Gynecologic Oncology
Patients undergoing surgery for gynecologic cancer, particularly those without insurance,...
Read More
Healthcare Costs for PPI or P-CAB-First for GERD
The objective of this study was to compare actual healthcare expenditures in GERD patients who...
Read More
Cost Effectiveness Analysis of Radiofrequency Ablation (RFA) Versus Stereotactic Body Radiotherapy (SBRT) for Early Stage Renal Cell Carcinoma (RCC).
To conduct a cost-effectiveness analysis of stereotactic body radiotherapy (SBRT) versus...
Read More
NMOSD & MOGAD Financial Burdens Impact QOL
Neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein-antibody...
Read More
Racial–Ethnic and Socioeconomic Disparities in Guideline-Adherent Treatment for Uterine Cancer
The goal of this study was to assess the relationship between race-ethnicity, and neighborhood...
Read More